Divis Labs

• 

  ChatGPT Was Asked To Choose Between Laurus And Divis Labs. Here's What It Replied.

  How ChatGPT refused to compare two pharma stocks and left the decision to us.

• 

  Divi's Labs Shares Decline Over 6% After Q4 Earnings

  Shares of Divi's Laboratories fell more than 6 per cent on Tuesday as the company's March quarter earnings failed to cheer investors. The stock dropped as much as 6.35 per cent to hit an intraday low of Rs 3,650.

• 

  Nifty Seen Opening Near 18,000; Sun TV, Divi's Labs In Focus

  Foreign institutional investors sold shares worth Rs 328 crore on Thursday while domestic institutional investors bought shares worth Rs 38 crore.

• 

  Sensex Up Over 500 Points, Nifty Above 17,600; Divi's Labs, NTPC Top Gainers

  Merck and company's partner Ridgeback Biotherapeutics said its experimental antiviral drug molnupiravir could halve chances of dying or being hospitalised; Divi's Laboratories makes the main ingredient of the drug

• 

  Divi's Labs Surges 10%, Hits Record High On Merck's Positive Data For Covid Drug

  Divi's Laboratories shares have so far this year advanced 38 per cent compared with Sensex which has gained 25 per cent.

• 

  Sensex Tumbles Over 400 Points, Nifty Settles Below 14,500

  Tata Consumer Products dived nearly 5 per cent to top the loser's list on the BSE, while pharma stocks such as Cipla, Dr Reddy's and Divi's Lab lost 1-3 per cent each

• 

  Sensex Ends 86 Points Higher, Nifty Reclaims 12,700 Led By Reliance Industries, ICICI Bank

  Eicher Motors, Bajaj Finserv, Coal India, Tata Steel and Divi's Labs, ending between 1.90 per cent and 7.46 per cent higher, were the top gainers in the 50-scrip Nifty basket.

• 

  UltraTech Cement, TCS, Divi's Labs Among Anand Rathi's Top Diwali Picks

  The benchmarks have staged a strong rally from the lows hit in March as the country went into lockdown to curb the spread of COVID-19 pandemic.

• 

  Divi's Labs Surges 16% To Hit New 52-Week High On Strong Earnings

  Divi's Labs shares have surged 125 per cent since August 14, the day it hit a 52-week low of Rs 1,466.

• 

  Divi's Lab Shares Pare Gains, Trade Flat After US FDA Closes Out Warning Letter

  The shares of Divi's Laboratories (Divi's Lab) pared early gains to trade 0.86% higher at Rs 1,018 on BSE at 3.10 pm. The scrip had hit 8% higher

• 

  Divi's Lab Shares Close 17% Higher As USFDA's Import Ban Set To Be Lifted From Vizag Plant

  Divi's Laboratories has informed the NSE in a stock exchange filing that the USFDA will soon lift the import Alert 66-40 and will move to close out the warning letter issued to the company's unit-II at Vishakhapatnam.

• 

  USFDA To Lift Import Alert On Visakhapatnam Unit: Divi's Labs

  The company had earlier said that the USFDA had issued an import alert under clauses 99-32 and 66-40 in March, and a warning letter later for the Vishakhapatnam facility.

• 

  USFDA issues Warning Letter To Divis Labs For Vishakhapatnam Unit

  The United States Food and Drug Administration (USFDA) has issued warning letter for the company's Unit-II at Vishakhapatnam, Divis Laboratories said in a BSE filing.

• 

  US Bans Divi's Factory, Shares Hit 3-Year Low

  The FDA has banned more than 40 Indian factories in recent years over quality control failures and manipulation of data.

• 

  Sensex Ends Flat For Third Day, Pharma Shares Fall

  Analysts expect a period of consolidation ahead as investors focus on individual stock movements as they wait for the earnings season to start in mid-April.